Skip to content
Call our team Request appointment

TMS for PTSD: What We Know

TMS is not FDA-cleared for post-traumatic stress disorder, and we want to say that before anything else, because you will find clinics that advertise it as if it were. What is true is more complicated. Several Veterans Affairs and university trials have found that TMS reduces PTSD symptoms, especially when combined with trauma-focused therapy. The largest Deep TMS trial for PTSD did not beat sham. The Department of Veterans Affairs and Department of Defense guideline currently says the evidence is insufficient to recommend for or against it.

The short answer

TMS is not FDA-cleared for PTSD and insurers do not cover it for PTSD alone. Some VA and university trials show meaningful symptom reduction, especially combined with trauma-focused therapy, while the largest Deep TMS PTSD trial did not beat sham. TMS is a covered option for the depression that accompanies about half of PTSD cases.

What TMS does reliably is treat depression, and about half of people with PTSD have depression too. For those patients, TMS is a covered, evidence-based option, and PTSD symptoms often improve alongside the mood. This page lays out what the studies show, what they do not, and how we approach veterans and trauma survivors in our TMS program.

Who it is for

The patient who benefits most clearly is an adult with PTSD and a co-occurring major depressive episode that has not responded to at least one antidepressant. That combination is common: in veteran and civilian samples, roughly half of people with PTSD have current depression, and the two together are harder to treat than either alone. Under the depression clearance, TMS is clinically appropriate and insurable for this patient, and the trauma symptoms are tracked alongside the mood. Patients with PTSD and no depression are not candidates under current clearances or coverage. We may consider an off-label course for such patients after a psychiatrist reviews the evidence with them, usually only when trauma-focused therapy and at least two medication trials have not been enough. Patients in acute crisis, with active substance dependence or with psychotic symptoms are not candidates until those issues are stabilized.

How it works

PTSD involves an overactive fear circuit, centered on the amygdala, and weak regulation of it by the prefrontal cortex, particularly the ventromedial and dorsolateral regions. The brain fails to learn that the danger has passed, which is why extinction-based therapies such as prolonged exposure and cognitive processing therapy work: they retrain that learning. TMS research has tried two main approaches. Low-frequency stimulation of the right dorsolateral prefrontal cortex is intended to dampen hyperarousal. High-frequency stimulation of the left or medial prefrontal cortex is intended to strengthen top-down control. Several trials pair stimulation with brief trauma script exposure or with a full course of therapy, on the theory that stimulating a circuit while it is engaged in extinction learning makes the learning stick. The results across these approaches are mixed, with the most consistent benefits appearing when TMS is added to therapy rather than used alone.

About 6 percent of U.S. adults will have PTSD at some point in their lives, and roughly half of people with PTSD also meet criteria for major depression.

Source: National Center for PTSD, U.S. Department of Veterans Affairs

In a randomized trial of 103 veterans receiving cognitive processing therapy, adding active low-frequency TMS over the right prefrontal cortex produced greater reductions in PTSD symptoms than sham TMS, with the difference maintained at six months.

Source: Kozel et al., Journal of Affective Disorders, 2018

In the largest sham-controlled trial of Deep TMS for PTSD, 125 patients received 12 sessions paired with brief trauma script exposure; both active and sham groups improved substantially and the active group did not separate from sham on the primary outcome.

Source: Isserles et al., Biological Psychiatry, 2021

In a naturalistic study of veterans treated with clinical TMS for depression across VA sites, those with comorbid PTSD showed clinically meaningful reductions in both depression and PTSD symptom scores.

Source: Madore et al., Journal of Affective Disorders, 2022

What to expect

Your evaluation can happen at any of our 13 offices or by video. A psychiatrist takes a trauma and mood history, scores the PCL-5 for PTSD and the PHQ-9 for depression, reviews medications and therapy to date, and screens for contraindications, including head injury with loss of consciousness, which is common in combat veterans and requires a closer look. If depression is present and criteria are met, our TMS coordinator submits authorization under the depression indication. Treatment sessions take place at our TMS treatment centers, with Palm Beach Gardens as the primary center: 36 sessions over about nine weeks. We track the PCL-5 and PHQ-9 weekly, and we encourage you to continue or start trauma-focused therapy during the course, since the evidence is strongest when the two are combined.

Benefits

  • Evidence-based and covered for the depression that accompanies about half of PTSD cases
  • PTSD symptoms, particularly hyperarousal and sleep, often improve alongside mood in naturalistic VA cohorts
  • No sedation, dependence or cognitive dulling, which matters for patients already on several medications
  • Can be combined with prolonged exposure or cognitive processing therapy, the pairing with the strongest evidence
  • Honest tracking with the PCL-5 and PHQ-9 so you and your psychiatrist can see what is and is not changing

Risks and side effects

Standard TMS side effects apply: scalp discomfort, headache in the first week and a rare seizure risk of roughly one in 30,000 sessions. Two issues are more relevant for trauma patients. Traumatic brain injury, including blast exposure, raises seizure risk and requires review of neurology records and sometimes imaging before we proceed; mild concussion without loss of consciousness is usually not a barrier. And a few patients find the clicking noise and the enclosed helmet unsettling at first; the technician will walk you through it slowly, and hearing protection is standard. Some trauma patients are on prazosin, benzodiazepines or high-dose stimulants, each of which we review: benzodiazepines may blunt response and stimulants can lower the seizure threshold.

Cost and insurance

No insurer, including Medicare, TRICARE or the VA community care program, covers TMS for PTSD as a standalone diagnosis. Coverage is available under the major depressive disorder indication when depression is present and documented, with the usual requirements: a PHQ-9 or HAM-D in the moderate to severe range, and for commercial plans two to four failed antidepressant trials plus a therapy trial. Veterans may be able to receive TMS for depression at a VA medical center, several of which run TMS programs, or through community care if the VA refers them. An off-label course for PTSD without depression is self-pay, and our TMS coordinator can quote current rates.

The regulatory and guideline status

TMS devices are FDA-cleared for major depressive disorder, OCD, anxious depression and smoking cessation. None is cleared for PTSD. The 2023 VA/DoD clinical practice guideline, the most influential PTSD guideline in the United States, reviewed the TMS literature and concluded that the evidence is insufficient to recommend for or against it. That is not a rejection. It is a statement that the trials are too small, too varied and too inconsistent to support a recommendation either way.

Insurance follows regulatory status. No insurer covers TMS for PTSD alone. Coverage is available for depression, including depression in a patient who also has PTSD, which in practice is the route by which most trauma survivors receive TMS.

The evidence, study by study

Early work

The first studies, in the 2000s, were small and used different targets and frequencies. Several reported reductions in PTSD symptoms, particularly with low-frequency stimulation of the right dorsolateral prefrontal cortex, but samples of 20 to 30 patients and inconsistent blinding limited what could be concluded.

Kozel and the VA trials

The most rigorous positive evidence comes from a series of Veterans Affairs studies led by Frank Kozel. In a 2018 trial, 103 veterans with PTSD received cognitive processing therapy, a standard trauma-focused treatment, and were randomized to active low-frequency TMS over the right prefrontal cortex or sham before each session. The active group improved more on PTSD symptom scales, and the advantage held at six months. A 2019 follow-up compared 1 Hz and 10 Hz stimulation and found both reduced symptoms, with no clear winner. These studies suggest TMS may make trauma-focused therapy work better, which is a different claim from TMS working on its own.

Theta burst in veterans

A 2019 trial from Providence VA randomized 50 veterans to 10 sessions of intermittent theta burst stimulation or sham. The active group showed modest benefit at two weeks that became clearer at one month, including improvements in social and occupational function. Small, short, but positive.

The Deep TMS PTSD trial

Deep TMS was tested for PTSD in a multicenter sham-controlled trial of 125 patients published in 2021. Each session was paired with a brief exposure to a personalized trauma script. Both groups improved substantially, and the active group did not separate from sham on the primary outcome. This is the largest and best-designed PTSD TMS trial to date, and it was negative. That has to weigh heavily in any honest assessment.

Naturalistic VA data

A 2022 study of veterans treated with clinical TMS for depression across VA sites found that those with comorbid PTSD had meaningful reductions in both PHQ-9 and PCL-5 scores. This is not a controlled trial, so it cannot separate TMS from expectation or from concurrent care, but it reflects how TMS is actually used for trauma patients: as a depression treatment that brings PTSD symptoms along with it.

StudyDesignResult
Kozel 2018103 veterans, TMS plus cognitive processing therapy vs sham plus therapyPositive; maintained at six months
Philip 201950 veterans, theta burst vs sham, 10 sessionsModestly positive, clearer at one month
Isserles 2021125 patients, Deep TMS with trauma script vs shamNegative; both groups improved equally
Madore 2022Naturalistic VA cohort treated for depressionPTSD and depression scores both improved
Cirillo 2019 meta-analysisPooled anxiety and PTSD trialsLarge pooled effect, small heterogeneous studies

How to read this evidence

Three patterns stand out. First, TMS added to trauma-focused therapy has done better than TMS alone, which fits what we know about the mechanism: stimulation strengthens whatever learning the circuit is doing at the time, and therapy is where extinction learning happens. Second, sham response in PTSD trials is large, larger than in depression trials, which makes it hard for any treatment to separate from placebo in a short study. Third, the field has not settled on a target or a frequency, which means studies are not really testing the same thing.

Our reading is that TMS is a plausible, still-unproven PTSD treatment, and a proven depression treatment for people who happen to have PTSD. We practice accordingly.

How Stedfast Psychiatry approaches trauma patients

When a veteran or trauma survivor comes to our TMS program, the evaluation covers both the trauma history and the mood history. We score the PCL-5 and the PHQ-9. If major depression is present with the PTSD, and at least one antidepressant has not been enough, the patient is a candidate under the depression clearance and insurance will usually cover the course. We treat with the standard 36-session depression protocol, track both scales weekly, and strongly encourage concurrent trauma-focused therapy, either with one of our therapists or with an existing one.

If depression is absent, we say so, recommend trauma-focused therapy and first-line medication if those have not been tried, and discuss off-label TMS only after that, with the trial results above on the table and self-pay cost made clear.

Special considerations for veterans

  • Head injury: blast exposure and concussion are common and raise seizure risk in proportion to severity. We review neurology records and imaging and proceed in most mild cases.
  • Medications: prazosin for nightmares is continued. Benzodiazepines may blunt response and are tapered when possible. High-dose stimulants and bupropion above 300 mg lower the seizure threshold and may be adjusted.
  • Substance use: heavy alcohol use raises seizure risk and lowers response. We ask for stability before starting.
  • VA coordination: we can coordinate with a veteran's VA psychiatrist and share records so that care is not duplicated. Some veterans receive TMS through the VA directly; others are referred to community care.
  • Environment: the TMS room is quiet and the technician explains every step. If an enclosed helmet or sudden noise is a trigger, tell us in advance and we will slow the first session down.

What to expect from a course if you have PTSD and depression

Sleep and hyperarousal usually shift first, in weeks two to four. Irritability and concentration often follow. Mood improves in the same window as it does for depression patients generally, between sessions 15 and 30. Intrusive memories and avoidance are the symptoms least likely to change from TMS alone and most likely to need therapy. By the end of the course, our goal is a measurable drop in both scales and a plan, with your therapist, for the trauma work that remains.

Stedfast Psychiatry's TMS program begins with an evaluation at any of our 13 offices or by video. Treatment sessions take place at our TMS treatment centers, with Palm Beach Gardens, 11641 Kew Gardens Ave, Suite 209, as the primary center. Call (561) 437-2199 to schedule a TMS evaluation.

Frequently asked questions

Is TMS FDA-cleared for PTSD?

No. TMS devices are FDA-cleared for major depressive disorder, OCD, anxious depression and smoking cessation. No device is cleared for PTSD. Any clinic advertising TMS as an FDA-cleared PTSD treatment is misstating the regulatory status. Research is ongoing, and a clearance in the future is possible, but the largest sham-controlled Deep TMS trial for PTSD did not beat sham, which means the evidence is not yet where it needs to be.

Does the VA offer TMS for PTSD?

Several VA medical centers run TMS programs, and veterans are treated primarily for depression, which is the cleared indication. Many of those veterans also have PTSD, and naturalistic VA data show that PTSD symptom scores improve alongside depression scores. The VA/DoD guideline does not recommend TMS as a PTSD treatment on its own because the controlled evidence is mixed. If you are a veteran with depression and PTSD, TMS through the VA or through community care for depression is a reasonable path.

If I have PTSD and depression, which one is TMS treating?

Officially, the depression. Clinically, both tend to move together. The two conditions share prefrontal regulation of the fear and mood circuits, and in VA cohorts the PCL-5 falls alongside the PHQ-9 during a depression course. Hyperarousal, sleep and irritability often improve most; intrusive memories and avoidance may need trauma-focused therapy to resolve. We track both scales weekly so the answer for you is measured, not assumed.

Should I do therapy at the same time as TMS?

Yes, if you can. The most consistent positive PTSD results come from trials that paired TMS with cognitive processing therapy or prolonged exposure, where stimulation appears to strengthen the extinction learning that therapy produces. TMS alone, without therapy, has the weakest and most mixed evidence for PTSD. If you are not currently in trauma-focused therapy, we can connect you with a therapist within the practice or coordinate with your existing one.

I had a concussion or blast injury. Can I still have TMS?

Usually, but it needs review. Traumatic brain injury raises seizure risk in proportion to its severity. A mild concussion without loss of consciousness and without ongoing symptoms is generally not a barrier. Moderate or severe injury, loss of consciousness, post-traumatic seizures or structural changes on imaging require neurology records and sometimes a new scan before we decide. Many veterans with blast exposure have received TMS safely. Bring any imaging reports and neurology notes to the evaluation.

Will TMS make me relive the trauma?

The standard depression protocol does not involve recalling the trauma at all. You sit in the chair, hear clicking, feel tapping on the scalp and can talk or sit quietly. Some research protocols pair stimulation with a brief trauma script, but that is not how Stedfast Psychiatry's TMS program delivers treatment. If you are also doing exposure therapy, that work happens with your therapist, not during the TMS session.

Can TMS help with nightmares and sleep?

Sleep is one of the earliest things to improve for many patients during a TMS course, and in PTSD cohorts the sleep and hyperarousal items on the PCL-5 are among those that move most. Trauma-specific nightmares respond best to prazosin or to imagery rehearsal therapy, and we often continue those alongside TMS. Expect better sleep continuity within the first few weeks if TMS is working for you; expect nightmares to need their own treatment.

What if I have PTSD but not depression?

Then TMS is off-label, not covered, and the evidence is mixed. We would recommend trauma-focused therapy, which has the strongest evidence for PTSD, and first-line medication such as sertraline, paroxetine or venlafaxine before considering TMS. If you have tried those and remain significantly symptomatic, a psychiatrist can discuss a self-pay off-label course with you, with the limits of the research stated clearly. We would rather you make that decision with accurate expectations.

Where this treatment is offered

Conditions this treats

If you are in crisis, call or text 988 or go to the nearest emergency room. Educational content; individual results vary. Reviewed by Dr. David Husted, board-certified psychiatrist.

Talk to our TMS coordinator

Tell us how to reach you and our scheduling team will help you explore appointment options. Most new patients are seen within one to two weeks, in person or by video. Medicare and most plans accepted; self-pay new-patient visits are $185.